Clinical Outcome Study of Medial Patellofemoral Ligament Reconstruction Surgery
IRB Number: 2013-133
inactiveMay 19, 2025
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Principal Investigator
Co-Investigators
- Sabrina M. Strickland, MD
- Douglas N. Mintz, MD, FACR
- Joseph Nguyen
- Irene Kalbian
Summary
This study is a review of the functional outcomes of MPFL reconstruction surgery for treating patellofemoral instability.
Inclusion/Exclusion Criteria
Inclusion:
Patients with patellofemoral instability who underwent MPFL reconstruction as part of their surgical treatment
Exclusion:
Revision surgery patients
Contact Information
Beth E. Shubin Stein, MD
212.606.1752